[go: up one dir, main page]

WO2008150074A3 - The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications - Google Patents

The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications Download PDF

Info

Publication number
WO2008150074A3
WO2008150074A3 PCT/KR2008/002806 KR2008002806W WO2008150074A3 WO 2008150074 A3 WO2008150074 A3 WO 2008150074A3 KR 2008002806 W KR2008002806 W KR 2008002806W WO 2008150074 A3 WO2008150074 A3 WO 2008150074A3
Authority
WO
WIPO (PCT)
Prior art keywords
diabetic complications
fractions
extracts
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2008/002806
Other languages
French (fr)
Other versions
WO2008150074A2 (en
Inventor
Sang Hoon Jung
Eun Ha Lee
Cheol-Ho Pan
Chul Young Kim
Byung Hun Um
Dong-Un Lee
Dae Geun Song
Joo Young Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Institute of Science and Technology KIST
Original Assignee
Korea Institute of Science and Technology KIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Institute of Science and Technology KIST filed Critical Korea Institute of Science and Technology KIST
Publication of WO2008150074A2 publication Critical patent/WO2008150074A2/en
Publication of WO2008150074A3 publication Critical patent/WO2008150074A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a composition for prevention and treatment of diabetic complications containing the extracts of Rhus verniciflua, fractions thereof and compounds isolated therefrom as an active ingredient, more precisely a composition for prevention and treatment of diabetic complications which comprises the extracts of Rhus verniciflua extracted by using water, alcohol or a mixture thereof as a solvent, fractions thereof and compounds isolated therefrom as an active ingredient. The extracts of Rhus verniciflua extracted by- using water, alcohol or a mixture thereof as a solvent, fractions thereof and compounds isolated therefrom were confirmed to have inhibitory effect on aldose reductase causing accumulation of sorbitol which is one of major causes of diabetic complications and on advanced glycation end procuct without cytotoxicity, so that they were confirmed to be safe materials effectively used for the composition for prevention and treatment of diabetic complications.
PCT/KR2008/002806 2007-06-05 2008-05-20 The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications Ceased WO2008150074A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2007-0054855 2007-06-05
KR1020070054855A KR100926454B1 (en) 2007-06-05 2007-06-05 The composition comprising the extracts, fractions and the isolated compounds of Rhus verniciflua for prevention and treatment of diabetic complications

Publications (2)

Publication Number Publication Date
WO2008150074A2 WO2008150074A2 (en) 2008-12-11
WO2008150074A3 true WO2008150074A3 (en) 2009-01-29

Family

ID=40094293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2008/002806 Ceased WO2008150074A2 (en) 2007-06-05 2008-05-20 The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications

Country Status (2)

Country Link
KR (1) KR100926454B1 (en)
WO (1) WO2008150074A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11738001B2 (en) 2017-11-24 2023-08-29 Otago Innovation Limited Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603685A (en) * 2011-01-19 2012-07-25 中国药科大学 Flavonoid fatty acid ester derivatives, preparation method and medicinal use of flavonoid fatty acid ester derivatives
WO2014185601A1 (en) * 2013-05-16 2014-11-20 (주)생명의나무 Pharmaceutical composition for preventing or treating menopausal symptoms containing flavonoid compound derived from toxicodendron vernicifluum extract as active ingredient
CN105837540B (en) * 2016-03-18 2018-06-15 中国林业科学研究院林产化学工业研究所 Method of the extraction with the sulphuretin and butein for inhibiting tyrosinase activity from lacquer tree wood powder
KR102216212B1 (en) * 2019-09-02 2021-02-17 박무순 Pharmaceutical composition comprising the fermentation product and powder of medicinal or edible natural products as an effective component for prevention or treatment of diabetes and health functional food comprising the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6413019A (en) * 1987-06-09 1989-01-17 Tsumura & Co Aldose reductase inhibitor
JPH09241165A (en) * 1996-03-04 1997-09-16 Snow Brand Milk Prod Co Ltd Suppressant for maillard reaction
JPH11130671A (en) * 1997-10-28 1999-05-18 Snow Brand Milk Prod Co Ltd Aldose reductase inhibitor
KR100377514B1 (en) * 2000-05-23 2003-03-26 신국현 Chalcone derivatives, method for preparation thereof and pharmaceutical composition containing the said derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6413019A (en) * 1987-06-09 1989-01-17 Tsumura & Co Aldose reductase inhibitor
JPH09241165A (en) * 1996-03-04 1997-09-16 Snow Brand Milk Prod Co Ltd Suppressant for maillard reaction
JPH11130671A (en) * 1997-10-28 1999-05-18 Snow Brand Milk Prod Co Ltd Aldose reductase inhibitor
KR100377514B1 (en) * 2000-05-23 2003-03-26 신국현 Chalcone derivatives, method for preparation thereof and pharmaceutical composition containing the said derivatives

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JEON W.K. ET AL.: "Anti-platelet effcts of bioactive compounds isolated from the bark of Rhus verniciflua Stokes", JOURNAL OF ETHNOPHARMACOLOGY, vol. 106, 2006, pages 62 - 69 *
JUNG C.H. ET AL.: "Rhus verniciflua Stokes Extract: Radical Scavenging Activities and Protective Effects on H2O2-induced Cytotoxicity in Macrophage RAW 264.7 Cell Lines", BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 29, no. 8, 2006, pages 1603 - 1607 *
OSAWA T. ET AL.: "Protective Role of Antioxidative Food Factors in Oxidative Stress Caused by Hyperglycemia", ANNALS OF THE NEW YORK ACADEMY SCIENCES, vol. 1043, 2006, pages 440 - 451 *
YAMAGISHI S. ET AL.: "Molecular mechanism of diabetic retinopathy: role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy", NIPPON GANKA GAKKAI ZASSHI, vol. 109, no. 6, 2005, pages 338 - 345 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11738001B2 (en) 2017-11-24 2023-08-29 Otago Innovation Limited Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders

Also Published As

Publication number Publication date
KR20080107049A (en) 2008-12-10
KR100926454B1 (en) 2009-11-13
WO2008150074A2 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
WO2010094860A3 (en) Method for extracting phenolic compounds from olive fruit water and preparation of an extract titrated with olive and grape polyphenols
WO2010079914A3 (en) A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases
WO2006079550A3 (en) Alcohol resistant dosage forms
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2007109804A3 (en) Extracts and methods comprising cinnamon species
WO2008150074A3 (en) The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications
WO2011041639A3 (en) Heteroatom containing substituted fatty acids
WO2011052950A3 (en) Pharmaceutical composition comprising indole compound
WO2009025532A3 (en) Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
WO2012075275A3 (en) Novel topical composition of sarracenia purpurea (pitcher plant)
WO2009077188A8 (en) Tea composition and process for the manufacture thereof
WO2008106979A3 (en) Pharmaceutical compositions comprising flavonoids and xylitol
WO2011046978A3 (en) Steroidal compounds as melanogenesis modifiers and uses thereof
WO2009146202A3 (en) Transketalized compositions, synthesis, and applications
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2010062122A9 (en) Composition for preventing or treating artherosclerosis
WO2009027382A3 (en) Sprayable composition containing red vine leaf extract
WO2011076867A3 (en) Plant extracts for treating neurodegenerative diseases
WO2010027221A3 (en) Skin-whitening composition comprising an extract, fraction or compound derived from lindera erythrocarpa
NZ601904A (en) Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts
WO2008098143A3 (en) Antimicrobial compounds and methods of use
WO2012088382A3 (en) Amyris alcohol and its ester for treating acne
WO2010143825A3 (en) Anti-arthritic agent using cyathula officinalis
WO2008086759A3 (en) Method of preparation and isolation of betulin diacetate from birch bark from paper mills and its optional processing to betulin
WO2011025120A3 (en) Composition for clearing hangovers and composition for restoring liver function using hot-spring water

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08753602

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08753602

Country of ref document: EP

Kind code of ref document: A2